Long-term results of the GEINO 1401 TRIAL: Randomizing patients to stop or to continue temozolomide until 12 cycles.

M. Domenech,Carles Fabregat Franco,Carlos Mesia,Anna Esteve,Sonia del Barco Berrón,Estela Pineda,Regina Gironés Sarrió,Ramon De Las Penas,José Luis Fuster,L Miguel Navarro,Miriam Alonso,Clara Olier,Pedro Pérez,Alfonso Berrocal,Marta Covela Rúa,Ainhoa Hernandez Gonzalez,Cristina Carrato,Carolina Sanz,J.M. Sanchez,Carmen Balana

Long-term results of the GEINO 1401 TRIAL: Randomizing patients to stop or to continue temozolomide until 12 cycles.

2021

2013Background: We previously presented our results of the GEINO 1401 trial that randomized patients diagnosed with glioblastoma and treated with chemoradiotherapy and adjuvant temozolomide (TMZ) f...

Keywords:

Chemoradiotherapy
Internal medicine
Glioblastoma
Temozolomide
Medicine
Oncology
Adjuvant
long term results

Correction
Source
Cite
Save

References

Citations